Latest News for: lutris

Edit

EGFR Inhibitors Induced Skin Disorders Market Research 2025-2035: Epidemiology, Regulations, Pipeline Analysis Featuring Azitra, Hoth Therapeutics, and Lutris Pharma - ResearchAndMarkets.com

Pharmiweb 02 Oct 2025
DUBLIN--(BUSINESS WIRE)--The "EGFR Inhibitors Induced Skin Disorders Market - A Global and Regional Analysis ... Risk factors for these skin disorders include the type of EGFR inhibitor used, the dosage, and the patient's skin type ... 1 ... 3.2.3 Lutris Pharma.
Edit

EGFR Inhibitors-Induced Skin Disorders Market Insights Highlight Expanding Outlook Till 2034, DelveInsight Evaluates | Lutris ...

GetNews 26 Sep 2025
The Key EGFR Inhibitors-Induced Skin Disorders Companies in the market include - Lutris Pharma, Hoth Therapeutics, TWi Biotechnology, Inc., and others ... Lutris Pharma, Hoth Therapeutics, TWi Biotechnology, Inc., and others ... Lutris Pharma.
  • 1
×